In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn’t responded to other treatments. Now, the agency is adding patients who are having suicidal thoughts or have recently attempted to harm themselves or take their own lives.
Nasal Spray Is A New Antidepressant Option For People At High Risk of Suicide
View Content